Hikma Pharmaceuticals USA, Inc.

Form 483

Eatontown, New Jersey, United StatesFEI 2250102Issued February 26, 2014

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2250102.

Observations1

Issue DateFebruary 26, 2014

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Hikma Pharmaceuticals USA, Inc.
Location: Eatontown, New Jersey, United States
FEI Number: 2250102
Product Type: Drugs
Issue Date: February 26, 2014
Country: United States

Inspection History, 2011 to 2019

NAI5

VAI3

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Hikma Pharmaceuticals USA, Inc. FDA Form 483, Eatontown, New Jersey, February 26, 2014